Beta Drugs IPO vs Shreeji Translogistics IPO

Comparison between Beta Drugs IPO and Shreeji Translogistics IPO.

IPO Details

Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while Shreeji Translogistics IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the Shreeji Translogistics IPO is up to ₹11.78 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Shreeji Translogistics IPO is ₹130.00 per share.

 Beta Drugs IPOShreeji Translogistics IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹85.00 per share₹130.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares1000 shares
Fresh Issue Size21,66,400 shares1,56,000 shares
Fresh Issue Size (Amount)up to ₹18.41 Crup to ₹2.03 Cr
OFS Issue Size0 shares7,50,000 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹9.75 Cr
Issue Size Total21,66,400 shares9,06,000 shares
Issue Size Total (Amount)up to ₹18.41 Crup to ₹11.78 Cr

IPO Timetable

Beta Drugs IPO opens on Sep 29, 2017, while Shreeji Translogistics IPO opens on Sep 29, 2017. The closing date of Beta Drugs IPO and Shreeji Translogistics IPO is Oct 04, 2017, and Oct 05, 2017, respectively.

 Beta Drugs IPOShreeji Translogistics IPO
Issue OpenSep 29, 2017Sep 29, 2017
Issue CloseOct 04, 2017Oct 05, 2017
Basis Of Allotment (Tentative)Oct 10, 2017Oct 10, 2017
Listing date (Tentative)Oct 12, 2017Oct 13, 2017

Financials & KPIs

Beta Drugs IPO P/E ratio is , as compared to Shreeji Translogistics IPO P/E ratio of .

 Beta Drugs IPOShreeji Translogistics IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets24.5415.208.01
Total Income41.6826.390.26
Profit After Tax5.181.130.11
NET Worth7.382.201.07
Reserves and Surplus6.371.190.06
Total Borrowing7.527.754.37
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets48.1239.5641.99
Total Income87.7588.4693.16
Profit After Tax1.581.040.47
NET Worth14.6513.0712.03
Reserves and Surplus11.3612.1311.09
Total Borrowing22.4718.9020.79
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)93.78%100%
Promoter Shareholding (Post-Issue)68.89%72.70%
Market Cap₹73.52 Cr.₹45.42 Cr.

Shares Offered

In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in Shreeji Translogistics IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Beta Drugs IPO and 0 shares in Shreeji Translogistics IPO.

 Beta Drugs IPOShreeji Translogistics IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation1,29,600 shares48,000 shares
QIB0 shares0 shares
NII10,83,200 shares4,53,000 shares
RII10,83,200 shares4,53,000 shares
Employee0 shares0 shares
Total21,66,400 shares9,06,000 shares

Bids Received (Subscription)

Beta Drugs IPO subscribed 18.97x in total, whereas Shreeji Translogistics IPO subscribed 1.25x.

 Beta Drugs IPOShreeji Translogistics IPO
NII (times)29.93x1.49x
RII (times)8.00x1.00x
Total (times)18.97x1.25x

Compare with others

Compare: